An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis

References

• Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26(s1):5–11.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen LM, Lu XS. Splenectomy and partial splenic artery embolization for the management of hypersplenism caused by portal hypertension. J Clin Med Pract. 2009;13:55–56.
   Google Scholar
• Tomikawa M, Akahoshi T, Sugimachi K, et al. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol. 2010;25(2):397–402.
   PubMed Web of Science ®Google Scholar
• Amin MA, Gendy MME, Dawoud IE, et al. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–1710.
   PubMed Web of Science ®Google Scholar
• Jiao SF, Chen HX, Wang YL, et al. Splenectomy versus partial splenic embolization for massive splenomegaly secondary to hepatitis B-related liver cirrhosis: a case-control study. Gastroenterol Res Pract. 2016;2016:3471626.
   PubMed Web of Science ®Google Scholar
• Weledji EP. Benefits and risks of splenectomy. Int J Surg. 2014;12(2):113–119.
   PubMed Web of Science ®Google Scholar
• Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134(4):647–653.
   PubMed Web of Science ®Google Scholar
• Kojouri K, Vesely SK, Terrell DR, et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104(9):2623–2634.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang YF, Zhang XH, et al. Evaluate the immediate effect of partial splenic embolization and splenectomy to the liver cirrhosis accompanied with hypersplenism. Chin J Clini Hepatol. 2005;21:284–285.
   Google Scholar
• Dwivedl MK, Pal RK, Dewanga L, et al. Efficacy of partial splenic embolisation in the management of hypersplenism. Indian J Radiol Imaging. 2002;12:371–374.
   Google Scholar
• N’Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179–184.
   PubMed Web of Science ®Google Scholar
• Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature. J Vasc Interv Radiol. 2007;18(4):463–481.
   PubMed Web of Science ®Google Scholar
• Sakai T, Shiraki K, Inoue H, et al. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci. 2002;47(2):388–391.
   PubMed Web of Science ®Google Scholar
• Wang YB, Zhang JY, Zhang F, et al. Partial splenic artery embolization to treat hypersplenism secondary to hepatic cirrhosis: a meta-analysis. Am Surg. 2017;83(3):274–283.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–615.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea BJ, O’Connell D, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa (Canada): OHRI; 2011 [cited 2020 Oct 15]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
   Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.
   PubMed Web of Science ®Google Scholar
• Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Qi X, Jia J, Bai M, et al. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a meta-analysis. J Clin Gastroenterol. 2015;49(6):495–505.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Wang F, Xu BG, Wang FM, et al. Comparison of efficacy between partial splenic artery embolization and splenectomy for hypersplenism. China Prac Med. 2020;15:12–15.
   PubMed Web of Science ®Google Scholar
• Wu GF. Efficacy comparison of splenectomy and partial splenic artery embolization in the treatment of hypersplenism. Public Med Forum Mag. 2020;24:68–69.
   Google Scholar
• Cui SL. Efficacy of splenectomy and partial splenic artery embolization in the treatment of hypersplenism. China Health Care Nutr. 2020;17:104.
   Google Scholar
• Xing WF, Zhou ZH, Huang YQ, et al. Comparison of curative effect between partial splenic embolization and splenectomy for hepatolenticular degeneration with hypersplenism. J Pract Med. 2019;35:3333–3342.
   Google Scholar
• Zhu J, Zhu H, Du HM, et al. Clinical comparative analysis of three surgical methods in the treatment of hypersplenism. Chongqing Med. 2018;47:1511–1514.
   Google Scholar
• Yin SL. Clinical analysis of interventional therapy for liver diseases. J Clin Med. 2016;3:285–288.
   Google Scholar
• Zhao YT, Wang DM, Li WH. Observation on patients with decompensated liver cirrhosis after splenectomy and partial splenic artery embolization. J Prac Hepatol. 2015;18:624–627.
   Google Scholar
• Ge YT. Comparison of the effect of splenectomy and splenic artery embolization in the treatment of liver cirrhosis with hypersplenism. China Health Ind. 2014;5:140–141.
   Google Scholar
• Liu YS, Ma GL, Li D, et al. Effect of interventional therapy in the treatment of cirrhotic hypersplenism. China Foreign Med Treat. 2014;22:39–40.
   Google Scholar
• Lin SC. Partial splenic artery embolization in the treatment of hypersplenism due to cirrhosis. Med Info. 2013;26:225.
   Google Scholar
• Wu L. Comparison of splenectomy and splenic artery embolization for the management of cirrhotic hypersplenism. World Health Digest Med Period. 2012;9:417.
   Google Scholar
• Wang P. Comparison of splenectomy and splenic artery embolization in the treatment of liver cirrhosis with hypersplenism. China Prac Med. 2012;7:92–93.
   Google Scholar
• Du PQ, Hu Y, Lu WS. Clinical effect of partial artery embolization and splenectomy for hypersplenism. Med J West. 2011;23:1883–1887.
   Google Scholar
• Yao CH. Clinical observation of partial splenic artery embolization in the treatment of hypersplenism due to cirrhosis. Changchun (China): Jilin University, 2010.
   Google Scholar
• Wang H, Ouyang HP. A comparative study on splenectomy vs partial splenic embolization for hepatic cirrhosis hypersplenism. J Clin Surg. 2008;16:674–675.
   Google Scholar
• Deng MH, Tang ZF, Xu RY, et al. Comparison of effects on treatment of cirrhotic hypersplenism between splenectomy and splenic artery embolization. China J Modern Med. 2006;16:1858–1860,1863.
   Google Scholar
• Su XK, Lin MQ, Zhou WS, et al. Effect of splenic artery embolization plus traditional Chinese medicine in the treatment of hypersplenism due to portal hypertension. Liaoning J Trad Chin Med. 2006;33:203–204.
   Google Scholar
• Mozes MF, Spigos DG, Pollak R, et al. Partial splenic embolization, an alternative to splenectomy-results of a prospective, randomized study. Surgery. 1984;96(4):694–702.
   PubMed Web of Science ®Google Scholar
• He XH, Gu JJ, Li WT, et al. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism. World J Gastroenterol. 2012;24:3138–3144.
   Web of Science ®Google Scholar
• Madoff DC, Denys A, Wallace MJ, et al. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics. 2005;25(1):S191–S211.
   PubMed Web of Science ®Google Scholar
• Faught WE, Gilbertson JJ, Nelson EW. Splenic abscess: presentation, treatment options, and results. Am J Surg. 1989;158(6):612–614.
   PubMed Web of Science ®Google Scholar
• Sangro B, Bilbao I, Herrero I, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18(2):309–314.
   PubMed Web of Science ®Google Scholar
• Zhu K, Meng X, Qian J, et al. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41(6):411–416.
   PubMedGoogle Scholar
• Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95(6):744–750.
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–221.
   PubMed Web of Science ®Google Scholar
• Zhu KS, Meng XC, Li ZR, et al. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol. 2008;66(1):100–106.
   PubMed Web of Science ®Google Scholar